课题基金 / 基金详情

ROLE OF THE SEROTONIN TRANSPORTER PROMOTER POLYMORPHISM IN PSYCHIATRIC DISORDERS

ROLE OF THE SEROTONIN TRANSPORTER PROMOTER POLYMORPHISM IN PSYCHIATRIC DISORDERS
血清素转运蛋白启动子多态性在精神疾病中的作用
批准号:
6097597
负责人:
DAVID GOLDMAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

DAVID GOLDMAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dysfunctions in serotonergic pathways may underlie several psychiatric disorders. The serotonin transporter (5-HTT) plays a critical role in the termination of serotonergic neurotransmission by Na-dependent uptake of serotonin by the presynaptic neuron. 5-HTT also represents the initial site of action of certain antidepressant drugs and neurotoxins. A functionally significant polymorphism in the 5-HTT promoter was identified (5HTTLPR). The polymorphism affects 5-HTT transcription and, ultimately, 5-HTT function. Frequency of the 5-HTTLPR was determined in a variety of clinical psychiatric populations including alcoholics; linkage and association studies were performed. Positive linkage was detected between 5-HTTLPR and the two anxiety-related personality traits available on the TPQ, at least partially replicating the reported association of this variant to behavior (see bibliography). In contrast, no association was found in Italian patients with obsessive compulsive disorders, panic disorders and eating disorders. However, two additional disease-specific findings were made: 1) in a collaboration with A. Malhotra and D. Pickar, 5-HTTLPR was found to be significantly associated with BPRS-rated psychoticism in schizophrenia and 2) in a collaboration with N. Rosenthal, HTTLPR was significantly linked with seasonal affective disorder and seasonality rating in SAD patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FLOW CYTOMETRY
CORE--CLINICAL RESEARCH
CORE--DEVELOPMENTAL CORE
CLINICAL RESEARCH...CORE